Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
Sci Rep ; 13(1): 16257, 2023 09 27.
Article in English | MEDLINE | ID: mdl-37759081

ABSTRACT

The coronavirus disease 2019 pandemic had a major impact on most medical services. Our aim was to assess the outcome of acute cholecystitis during the nationwide lockdown period. All patients admitted to our emergency department for AC were analysed. Patient characteristics, performance status, AC severity, treatment modality and outcome of AC were assessed during the lockdown period (Period II: 1 April 2020-30 November 2021) and compared to a historical control period (Period I: 1 May 2017-31 December 2018). AC admissions increased by 72.8% in Period II. Patients were younger (70 vs. 74 years, p = 0.017) and greater in number in the CCI 1 group (20.4% vs. 11.2%, p = 0.043) in Period II. The unplanned readmission rate (6.3 vs. 0%, p = 0.004) and the gallbladder perforation (GP) rate was higher (18.0 vs. 7.3%, p = 0.006) in Period II. Percutaneous transhepatic gallbladder drainage (PTGBD) was more frequent (24.1 vs. 12.8%, p = 0.012) in Period II. In addition to a drop in patient age and CCI, a significant rise in the prevalence of acute cholecystitis, GP and unplanned readmissions was observed during the nationwide lockdown due to the COVID-19 pandemic. PTGBD was more frequent during this period, whereas successful conservative treatment was less frequent.


Subject(s)
COVID-19 , Cholecystitis, Acute , Humans , Pandemics , Drainage , Retrospective Studies , COVID-19/epidemiology , Communicable Disease Control , Cholecystitis, Acute/epidemiology , Cholecystitis, Acute/therapy , Treatment Outcome , Gallbladder/surgery
3.
Neoplasma ; 57(3): 270-9, 2010.
Article in English | MEDLINE | ID: mdl-20353280

ABSTRACT

The results of treatment of acute promyelocytic leukemia, when combination ATRA + chemotherapy is used in induction and maintainance therapy and risk adapted strategy applied in consolidation, improved at present time. Enhanced supportive therapy also contribute to improved outcome of APL patients. 3 - year relapse free, overall survival and clinical and biological presenting features of APL patients were evaluated. Since January, 2001 till March, 2009, 32 patients treated with modified spanish treatment scheme were assessed. After june 2003 risk adapted strategy in protocol therapy according to spanish treatment group with ATRA and anthracyclines in consolidation therapy in high and intermediate risk patients was used. Cytoreduction therapy in patients with initially high leukocyte count was the modification of spanish treatment scheme. 29 (90.6%) patients achieved complete hematologic remission, 2 (6.3 %) molecular relapses were observed, death was observed in 4 patients (12.5%). The estimated 3-year OS was 90.6%; 95% CI (80.5%-100.0%), and estimated 3-year RFS was 95.5 %; 95 % CI (86.8%-100.0%). Survival results correspond with other published clinical studies. The number of relapses was slightly lower and the incidence of ATRA syndrome (50%) was higher when compare with the results of other study groups. Current recommendations for treatment with risk-adapted strategy for patients with newly diagnosed acute promyelocytic leukemia resulted in our patients group to comparable outcome and good compliance like in other published studies.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Leukemia, Promyelocytic, Acute/drug therapy , Adolescent , Adult , Aged , Female , Follow-Up Studies , Humans , Leukemia, Promyelocytic, Acute/mortality , Male , Middle Aged , Tretinoin/administration & dosage
4.
Bratisl Lek Listy ; 109(8): 358-61, 2008.
Article in English | MEDLINE | ID: mdl-18837244

ABSTRACT

Isolated extramedullary relapse (IEMR) of acute leukemia (AL) after allogeneic bone marrow transplantation (BMT) is a rare occurrence. It is seen more commonly after BMT than after conventional chemotherapy (CHT) alone. We describe the natural history and response to treatment in four patients with IEMR following allogeneic BMT. The results indicate a stronger graft-versus-leukemia (GVL) effect in the marrow than in the peripheral tissues (Fig. 4, Ref. 13). Full Text (Free, PDF) www.bmj.sk.


Subject(s)
Bone Marrow Transplantation/adverse effects , Leukemia, Myeloid, Acute/surgery , Leukemic Infiltration/etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/surgery , Adult , Brain/pathology , Breast/pathology , Female , Graft vs Leukemia Effect , Humans , Leukemic Infiltration/pathology , Middle Aged , Skin/pathology , Transplantation, Homologous/adverse effects
5.
Neoplasma ; 54(5): 424-30, 2007.
Article in English | MEDLINE | ID: mdl-17688372

ABSTRACT

We describe the implementation, optimization, sensitivity determination and first clinical results of polymerase chain reaction (PCR) amplification of polymorphic short tandem repeat (STR) markers and Amelogenin locus coupled with fluorescent detection and capillary electrophoresis in chimerism monitoring of patients transplanted at three different transplant centers using a commercially available multiplex microsatellite assay. The chimerism analysis was performed with genomic DNA extracted from unselected peripheral blood leukocytes of one hundred pediatric and adult patients, who underwent allogeneic stem cell transplantation (SCT) from human leukocyte antigen (HLA) matched or one antigen mismatched related or unrelated donors for malignant (70 patients) and non-malignant (30 patients) diseases. Tested were 79 donor recipient pairs for 15 STR systems and identified an informative marker in all but one of them (98,7%), using 6 selected systems out of these fifteen, that appeared highly informative in our patients population. In 21 sex-mismatched donor recipient pairs we used the Amelogenin locus to distinguish the X and Y chromosome. In sixty-three out of these 100 patients chimerism was regularly analyzed from blood samples taken at various time points after SCT with the median follow up of 17 months. Complete chimerism (CC), maintained over the whole follow-up period, was detected in 24 (38, 1%), stable and decreasing mixed chimerism (MC) in 28 (44, 4%) and increasing MC in 11 patients (17, 5%). Patients with CC, stable and decreasing MC showed a significantly better (p 0,005) overall survival rate (0, 81), compared to those with increasing MC (0, 24). These results demonstrate that STR-based chimerism monitoring with sensitivity above 1% and high informativity (98, 7% of donor recipient pairs) is necessary in establishing the origin of engrafted cells after an allogeneic SCT, in detecting graft rejection and that it may contribute in identifying patients with imminent leukemia relapse.


Subject(s)
Amelogenin/genetics , Gene Amplification , Leukemia/therapy , Polymerase Chain Reaction , Stem Cell Transplantation , Transplantation Chimera , Adolescent , Adult , Child , Child, Preschool , Chromosome Mapping , Female , Genetic Markers , Humans , Infant , Leukemia/genetics , Leukemia/mortality , Lymphoma/genetics , Lymphoma/mortality , Lymphoma/therapy , Male , Middle Aged , Monitoring, Physiologic , Recurrence , Survival Analysis , Tandem Repeat Sequences , Transplantation, Homologous
6.
Acta Physiol Acad Sci Hung ; 60(3): 155-64, 1982.
Article in English | MEDLINE | ID: mdl-6821017

ABSTRACT

The effect of the Ca-chelators EDTA and EGTA on sinoatrial activity and heart irritability was studied in dog experiments by perfusing the artery supplying the sinoatrial node. Beside the usual ECG recordings left and right atrial and left and right ventricular epicardial electrograms, His-bundle electrogram and the early activity of the sinoatrial node were recorded. In addition action potentials were recorded from the left auricle and right ventricle of the dog hearts. Local application around the sinoatrial and atrio-ventricular nodes of EDTA and EGTA caused sinus bradycardia and later sinus arrest within 1 min after introduction of the drugs. For substitution of the sinus rhythm junctional (seldom lower atrial) escape rhythm developed. One to two minutes later it was followed by atrial premature beats and even later atrial flutter and fibrillation could be recorded. In one third of the cases atrial fibrillation was followed by secondary ventricular fibrillation. Atrio-ventricular impulse conduction was prolonged in the av node by EDTA and EGTA. Atrial action potentials and the slow (Ca dependent) ventricular action potentials were depressed by EDTA and EGTA.


Subject(s)
Arrhythmias, Cardiac/physiopathology , Edetic Acid/pharmacology , Egtazic Acid/pharmacology , Ethylene Glycols/pharmacology , Heart/drug effects , Sinoatrial Node/physiology , Animals , Arrhythmias, Cardiac/chemically induced , Dogs , Electrocardiography , Heart/physiology , Heart/physiopathology , Sinoatrial Node/drug effects , Sinoatrial Node/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL